Director, Clinical Supply Chain

Role: Lead end-to-end clinical supply chain management for Olema's late-phase oncology programs, ensuring uninterrupted drug supply for pivotal Phase 3 trials. Responsibilities: develop and execute global supply strategies, oversee manufacturing, distribution, and inventory management, manage third-party vendors, lead risk mitigation and contingency planning, and support supply readiness for regulatory submissions and potential commercialization. Collaborate cross-functionally with Clinical Operations, CMC, Quality, Regulatory, and external partners to align supply plans with study timelines, enrollment, and manufacturing schedules. Requirements: Bachelor's in a scientific, engineering, or related discipline; 15+ years in biotech/pharma with 8+ years in clinical supply chain management; deep knowledge of GMP, global regulations, and end-to-end clinical supply processes; experience managing complex, late-phase, global clinical trials, including oncology. Preferred: oncology clinical trial experience, knowledge of comparator/drug supply, and experience supporting NDA readiness. Attributes include strategic thinking, leadership, proactive risk management, and strong cross-functional collaboration. Location: SF or Cambridge, with occasional travel.